TelecomTV TelecomTV
  • News
  • Videos
  • Channels
  • Events
  • Directory
  • Smart Studio
  • Surveys
  • Debates
  • Perspectives
  • DSP Leaders World Forum
  • DSP Leaders
  • Great Telco Debate
    • |
    • Follow
    • |
    • Subscribe
  • |
  • More
  • Webcasts
  • Surveys
  • Debates
  • Perspectives
  • Great Telco Debate
  • |
  • Follow TelecomTV
  • |
    • Subscribe
    • |
  • About
  • Privacy
  • Help
  • Contact
  • Follow TelecomTV
  • About
  • Privacy
  • Help
  • Contact
  • Sign In Register Subscribe
    • Subscribe
    • Sign In
    • Register
  • Search

Tracker

TelecomTV TRACKER

Sourced by TelecomTV's TRACKER platform
from Oracle Press Room

Tracker

Large South Korean Contract Research Organization Selects Oracle Health Sciences InForm to Speed Clinical Trials

Via Oracle Press Room

Sep 30, 2015

LSK Global PS optimizes clinical development processes with Oracle Health Sciences cloud solution

Redwood Shores, Calif.—Sep 30, 2015


Oracle Health Sciences today announced that LSK Global Pharma Services (LSK Global PS), the leading full-service contract research organization (CRO) in South Korea, has adopted cloud-based Oracle Health Sciences InForm to improve its clinical development processes, streamline data capture, and speed up trial timelines.

LSK Global PS offers task flow, product development, regulatory consulting, project development, clinical research, data management, and other CRO services. The company also conducts clinical trials for many local pharmaceutical firms. LSK Global PS looked to Oracle for a solution that would enable its R&D team to access real-time clinical trial data, reduce invalid data entries, and expedite the availability of drug trial information.

LSK Global PS plans to utilize Oracle’s best-in-class technology to gain deeper and faster insight into its clinical data, which will help the company save time and effort. In turn, the CRO will be able to help sponsors improve the speed, quality, and efficiency of their clinical studies.

Oracle Health Sciences InForm offers comprehensive support for industry standards, such as CDISC, to increase efficiency and time for trial design and setup and enhance data collection and reporting quality.

“LSK Global PS is the first CRO in South Korea to conduct a successful global new-drug development clinical study. It is our goal to advance Korean domestic clinical trial quality standards to those at the global level,” said Dr.Young Jack Lee, chairman and chief executive officer, LSK Global PS. “To support our growing global business needs, the Oracle Health Sciences InForm electronic data capture system provides us with the confidence to meet our expanding global customer demands and helps ensure that we have access to accurate data at all times.”

In addition, with Oracle Health Sciences InForm’s intuitive dynamic data entry displays, LSK Global PS will be able to accelerate data collection and improve the end user experience at clinical investigator sites.

“Today, CROs are challenged by increasingly complex global clinical trials, shrinking R&D resources, and smaller budgets—all in a more competitive environment,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “With more than 15 years of electronic data capture experience in the clinical industry, Oracle Health Sciences helps leading CROs—such as LSK Global PS—to not only optimize their study start-up processes, but to also be prepared with value-based clinical innovation solutions that enable a strategic advantage for their sponsor customers.”

Oracle and the Galien Foundation

Through its solutions, Oracle Health Sciences helps global CROs such as LSK Global PS push clinical trial boundaries and create an environment for innovation and discovery.

Extending its commitment to health science innovation, Oracle Health Sciences will be participating in the sixth annual Galien Forum and Prix Galien USA awards ceremony. The Galien Foundation is internationally renowned for recognizing the development of innovative medicines and medical technologies that advance pharmaceutical research and improve the state of human health.

Related Topics
  • Asia-Pacific,
  • Cloud,
  • Contract Award,
  • Digital Platforms & Services,
  • News,
  • Oracle,
  • Tracker

More Like This

Open RAN

5G solution providers sign up to SONIC

Feb 28, 2021

Access Evolution

Deutsche Telekom exceeds 100 billion euros of revenue in record year 2020

Feb 26, 2021

Edge

Akraino Release 4 enables Kubernetes across multiple edges, integrates across O-RAN, Magma, and more

Feb 26, 2021

5G

MyDIGITAL is critical to advance Malaysia and the key is in its execution

Feb 26, 2021

Digital Platforms & Services

Recovery plans in Europe and investments in traditional and emerging technologies: An IDC overview

Feb 26, 2021

This content extract was originally sourced from an external website (Oracle Press Room) and is the copyright of the external website owner. TelecomTV is not responsible for the content of external websites. Legal Notices

Email Newsletters

Stay up to date with the latest industry developments: sign up to receive TelecomTV's top news and videos plus exclusive subscriber-only content direct to your inbox – including our daily news briefing and weekly wrap.

Subscribe

Top Picks

Highlights of our content from across TelecomTV today

On-demand Workshop: How to build your cloud native 5G core platform

16:48

The case for mmWave in 5G networks

25:55

The Private Mobility Opportunity for Enterprises

12:04

VMware learnings from DISH 5G rollout

  • TelecomTV
  • Decisive Media

TelecomTV is produced by the team at Decisive Media

Menu
  • News
  • Videos
  • Channels
  • Directory
  • Smart Studio
 
  • Surveys
  • Debates
  • Perspectives
  • Events
  • About Us
Our Brands
  • TelecomTV Tracker
  • TelecomTV Perspectives
  • DSP Leaders
  • DSP Leaders World Forum
  • The Great Telco Debate
Get In Touch
[email protected]
+44 (0) 207 448 1070

Request a Media Pack

Follow
  • © Decisive Media Limited 2021. All rights reserved. All brands and products are the trademarks of their respective holder(s).
  • Privacy
  • Terms
  • Legal Notices